It's for this reason the constant delays are not only frustrating but heartbreaking. Statistically, one more child would still be alive (and cured) after 3 years with a dose of Remestemcel and still we wait. AA would mean more revenue to the company for better scientists, greater research streams and the means to finance more trials to further investigate potency assays and dosage regimes to possibly turn that 2 out of 4 children into 4 out of 4.
Cell Therapy News/Articles, page-15416
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
-0.040(3.54%) |
Mkt cap ! $1.244B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.14 | $1.09 | $10.61M | 9.616M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 241716 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.10 |
Change
-0.040 ( 3.00 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.14 | $1.09 | 1809171 | ||
| Last updated 15.59pm 09/05/2024 ? | |||||
| MSB (ASX) Chart |